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were the subjects of this study. Baseline blood hematology, biochemistry, and bone panel were done. Blood was collected, and
three TaqMan-MGB probes were used to analyze SNP variants in ALOX15 (rs7220870), LRP5 (C 25752205 10), and TNFRSF11B
(C 11869235 10). Results. The variant of ALOX15 17p13 showed that the BMD of the spine was lower in the AA allele (P value
< 0.002) and fractures were highest at 50% compared to CC allele. In the TNFRSF11B gene, BMD of the hip and spine was
signiﬁcantly higher in the GG allele and the history of fractures was signiﬁcantly higher in GG group. With regard to the LRP5
(C 25752205 10) gene, there was no signiﬁcant diﬀerence between allele groups. Conclusion(s). This study shows that the genetic
inﬂuence of osteoporosis in the Caucasian and Saudi Arabians population is similar. We believe that the same genetic markers that
inﬂuence osteoporosis in the Caucasian race could be used for further studies in the Saudi Arabian population.
1.Introduction
Postmenopausal osteoporosis (PMO) has become a major
epidemic of the last millennium and is expected to be a
problem for health care providers in the present millennium
as well. Osteoporosis is a disease in which the net loss
of bone exceeds bone formation, and it occurs in women
after estrogen loss in postmenopause [1–3]. Postmenopausal
osteoporosis (PMO) is a major public health epidemic
worldwide. Most women with PMO present with a fracture
as the ﬁrst indication of the disease [4]. It is estimated that,
in USA, 25 million women suﬀer from osteoporosis, and the
cost to treat osteoporosis-related fractures (ORFs) exceeds
$10 billion a year [5, 6]. The prevalence of PMO in Saudi
Arabia and the recognition of the problems associated with
PMO were only realized in the last decade. Only few studies
about PMO in Saudi Arabian women have been reported
[7–10].
The most serious complication of osteoporosis is hip
fracture, which increases patients’ morbidity and mortality
rates. The incidence and costs of these fractures and their
sequelae will continue to rise as the population ages; by year
2025, costs related to osteoporotic fractures are projected
to reach $25.3 billion in the United States alone [11].
In an assessment of the annual cost of ORF in Saudi
Arabia, Bubshait and Sadat-Ali (2007) [12] found that SR
4.27 billion is spent yearly to treat osteoporosis-related
femoral fractures. Osteoporotic hip fracture usually requires
hospitalization and surgery and may result in lengthy or
permanentdisabilityorevendeath.Withintheﬁrstyearafter
injury, a patient with a hip fracture has a 1015% greater
chance of dying than others of the same age. Men, though
suﬀering fewer hip fractures than women, are 25% more
likely than women to die within one year of the injury
[13–15].2 Journal of Osteoporosis
From family histories, twin studies, and molecular
g e n e t i c s ,i ti sq u i t ee v i d e n tn o wt h a ts o m eo fap a t i e n t ’ s
predisposition for osteoporosis can be inherited. Genetic
control of osteoporosis is polygenic; enumeration of the
speciﬁc genes involved is in the initial phases [2, 16–18].
There is no study, as yet, about the genetic inﬂuence on
osteoporosis and related fractures in Saudi Arabian women.
This study is conducted to ﬁnd the inﬂuence of known
genes on osteoporosis among Saudi Arabian women with
and without fractures.
2.MaterialandMethods
After approval of the ethical and review board of the Uni-
versity of Dammam and written consent from the patients,
two-hundred ethnic Saudi Arabian women with diagnosis of
postmenopausalosteoporosisbyDEXAmachineonthebasis
of T and Z scores, as described by WHO, were the subjects
of this study, which was done between January 2009 and
June 2010. History and clinical examination were done to
rule out secondary osteoporosis. Baseline blood hematology,
biochemistry, and bone panel were also done. For the genetic
analysis, 5mL of whole blood was collected. Out of several
candidate osteoporosis genes which have been reported in
the Caucasian race to inﬂuence BMD and fragility fractures,
we did genotyping of 3 polymorphisms in three genes as a
pilot study in ethnic Saudi Arabian postmenopausal women.
The three genetic polymorphisms have been convincingly
shown to aﬀect the BMD and fragility fractures in the
white race. Three TaqMan-MGB probes (two predesigned
and one on design assays) have been used to analyze SNP
variants in the requested genes: Alox15 (rs7220870), LRP5
(C 25752205 10), and TNFRSF11B (C 11869235 10). DNA
from 100µL blood samples has been extracted using the
DNeasy Tissue Extraction kit from Qiagen. Positive DNA
control of known genotype (wild type, heterozygote, and
mutant) was added to the PCR as well as negative control
(no DNA). Genotyping was visualized on Taqman 7000
(Applied Biosystems). The data of the patients including age,
history of fractures, and hip and spine BMD was entered
and analyzed using SPSS Inc.’s Statistical Package for Social
Sciences (SPSSs), version 14.0 (Chicago, IL, USA). Data is
expressed as mean and standard deviation (SD). Statistically
signiﬁcant diﬀerences between groups were determined with
aS t u d e n tt test. P values less than .05 and a CI of 95% were
used to indicate statistical signiﬁcance.
3. Results
The average age of the patients was 62.5 ± 5.9y e a r s .T h e
variant of ALOX15 17p13 (rs7220870), C >ASNP where
C is the ancestral allele (freq. 0.7–0.9), and the A allele
is the variant allele (freq. 0.1–0.3). Majority (69%) of the
women were CC (homozygous for the C allele); even though
BMD in the hip region was signiﬁcantly lower (P<0.001,
CI 0.017 to 0.06), history of fractures were lower than the
other two alleles (P<0.0002, CI 3.4 to 15.7) Table 1(a).
The number of women in the homozygous for A allele was
4% with a higher BMD. A history of fractures was found
in 50% of the patients (P<0.001) (Table 1(b)). Regarding
the analysis of the LRP5 rs3736228, the alleles were C >T
SNP where C is the ancestral allele (freq. 0.7–0.9) and the
T allele is the variant allele (freq. 0.1–0.3). Table 2 gives the
data of the LRP5 gene. Over 96% of the patients exhibited
the CC and CT alleles. In women with the homozygous T
allele the BMD was signiﬁcantly higher at the hip and spine
and there were no fragility fractures. The statistical analysis
of the LRP5 gene and SNP is given in Table 2(b). In the
TNFRSF11B (C 11869235 10) gene, the majority of patients
belonged to the AA and AG alleles, which was homozygous
a n dh e t e r o z y g o u sf o rt h eAa l l e l e ,a n do n l y3 %b e l o n g e dt o
the GG allele. BMD of the hip and spine was signiﬁcantly
higher in the GG allele, but the history of fractures was more
common in the GG group P<0.001 (CI 59.85 to 60.146)
(Tables 3(a) and 3(b)). In the A allele group, there was risk of
low BMD and higher risk for osteoporosis without fractures,
whereas, in patients with the G allele, there was higher BMD
of both hip and spine and higher prevalence of fractures.
4. Discussion
Our study provides evidence that earlier reported SNPs in
the ALOX 15, LRP5, and TNFRS11B, which inﬂuences
BMD,osteoporosis,andfragilityfracturesinCaucasians,also
inﬂuences the condition in ethnic Saudi Arabian females.
Tranah et al. [19] found that the T/T genotype of ALOX15
had a 33% higher rate of osteoporosis fractures. In this
study we found that although only 4% of the women carried
the genotype, the fracture rate in those who carried it was
50%. Contrary to our ﬁnding and that of Tranah et al.
[19], Mullin et al. [20] reported that polymorphisms in
ALOX15 are not associated with inﬂuencing BMD in white
men and women. Low-density lipoprotein receptor-related
protein 5 (LRP5) was reported to inﬂuence BMD and risk of
fractures. Variations of LRP5 have been linked to BMD and
susceptibility to osteoporosis, but Koller et al. [21]s u g g e s t e d
that LRP5 was not a major inﬂuence on attainment of peak
BMD of the hip and spine in white women. Van Meurs
et al. [22] reported that their ﬁndings indicate that LRP5
does inﬂuence BMD and fracture risk throughout life in
the general population. Mizuguchi et al. [23] found that
Japanese women with the C/C genotype had higher adjusted
BMD (AdjBMD) value compared to those with C/T and T/T
(P = 0.022), but in Saudi women the C/C genotype had
the lowest BMD in the hip and spine, and women with the
TT allele had no fragility fractures compared to CC and CT
variants. Brixen et al. [24] meanwhile, found no signiﬁcant
diﬀerence in BMD between the three alleles in white men.
The distribution of CC, CT, and TT alleles in this study was
73.5%, 23%, and 3.5% and similar frequency. The CC, CT,
and TT genotypes were found in 75.6%, 21.8%, and 2.6% of
the participants, respectively [25].
Richards et al. [26] reported strong evidence of asso-
ciation with SNP in rs4355801 on chromosome 8, near
TNFRSF11B, along with BMD and increased risk of osteo-
porosis. They found that the G allele at rs4355801 wasJournal of Osteoporosis 3
Table 1: (a) Demographic data of ALOX15 17p13 (rs7220870) of CC, CA, and AA alleles. (b) Statistical analysis of the ALOX15 17p13
(rs7220870) 3 alleles.
(a)
Parameter CC (138) CA (54) AA (8)
Age years 62.3 ±5.75 9 .94 ±6.96 1 .4 ±11.5
BMD hip g/cm2 0.429 ±0.10 .468 ±0.11 0.581 ±0.26
Ts c o r e −2.8 ±0.6 −2.6 ±0.9 −2 ±1.8
Zs c o r e −1.6 ±0.7 −1.1 ±0.9 −0.74 ±1.5
BMD spine g/cm2 0.680 ±0.08 0.712 ±0.12 0.662 ±0.22
Ts c o r e −3.25 ±0.9 −3.07 ±0.7 −2.54 ±1.22
Zs c o r e −2.02 ±0.68 −1.81 ±0.93 −2 ±0.7
No. of fractures (%) 39 (28.2) 23 (42.6) 4 (50)
(b)
Parameter Alleles P value (CI)
Age CC versus CA
C C+C Av e r s u sA A
0.002 (2.092–2.62)
0.8
BMD hip CC versus CA
C C+C Av e r s u sA A
0.001 (0.017–0.06)
0.001 (0.111–0.159)
BMD spine CC versus CA
C C+C Av e r s u sA A
0.002 (0.024–0.04)
0.01 (0.045–0.012)
History of fractures CC versus CA
C C+C Av e r s u sA A
0.0002 (3.4–15.7)
0.001 (60.8–61.4)
Table 2: (a) Demographic data of LRP5 (C 25752205 10) of CC, CT, and TT alleles. (b) Statistical analysis of the LRP5 (C 25752205 10) 3
alleles.
(a)
Parameter CC (147) CT (46) TT (7)
Age years 62 ±10.96 0 .4 ±8.96 0 ±12
BMD hip g/cm2 0.443 ±0.15 0.445 ±0.14 0.539 ±0.06
Ts c o r e −2.7 ±1.1 −2.65 ±0.8 −2.05 ±0.7
Zs c o r e −1.5 ±3.6 −1.1 ±0.7 −0.9 ±0.5
BMD spine g/cm2 0.687 ±1.40 .70 ±0.13 0.9 ±0.5
Ts c o r e −3.16 ±0.97 −3.26 ±1.02 −2.35 ±0.28
Zs c o r e −1.8 ±0.9 −2.07 ±1.3 −1.75 ±0.6
No. of fractures (%) 51 (34.2) 15 (32.6) 0
(b)
Parameter Alleles P value (CI)
Age CC versus CT
C C+C Tv e r s u sT T
0.7
0.6
BMD hip CC versus CT
C C+C Tv e r s u sT T
0.8
0.001 (0.065–0.107)
BMD spine CC versus CT
C C+C Tv e r s u sT T
0.2
0.001 (0.166–2.540)
History of fractures CC versus CT
C C+C Tv e r s u sT T
0.01 (35.8–36.20)
0.001 (32.8–33.14)
associated with higher BMD, and the A allele with low BMD,
while in our patients the BMD, was signiﬁcantly higher with
G alleles as compared to AA or AG alleles (P<0.001; CI <
−0.1966) and lower in AA or AG alleles. Even though the
risk of osteoporosis was higher in patients with the A allele,
the fracture prevalence was not increased. Our results concur
with the ﬁndings of Richards et al. with regard to the risk of
fractures with the A allele.
Our study has limitations and certain strengths. The
number of osteoporotic patients was small, compared to4 Journal of Osteoporosis
Table 3: (a) Demographic data of TNFRSF11B (C 11869235 10) of AA, AG, and GG allele. (b) Statistical analysis of the TNFRSF11B
(C 11869235 10) 3 alleles.
(a)
Parameter AA (114) AG (80) GG (6)
Age years 61.6 ±10.96 1 .2 ±9.8 69.5±12
BMD hip g/cm2 0.461 ± 0.15 0.443 ±0.16 0.726 ±0.55
Ts c o r e −2.7 ±1.27 −2.75 ±0.96 −1.1 ±2.5
Zs c o r e −1.33 ±0.96 −1.21 ±0.92 −0.15 ±2.7
BMD spine g/cm2 0.686 ± 0.13 0.689 ±0.11 0.915 ±0.53
Ts c o r e −3.2 ±1.0 −3.14 ±0.96 −1.1 ±2.7
Zs c o r e −1.92 ±1 −1.72 ±1.4 −2.35 ±0.5
No. of fractures (%) 38 (33.3) 25 (31.25) 3 (50)
AA: homozygous for A allele, AG: heterozygous allele, and GG: homozygous for G allele.
(b)
Parameter Alleles P value (CI)
Age AA versus AG
A A+A Gv e r s u sG G
0.2
0.001(8.191–8.808)
BMD hip AA versus AG
A A+A Gv e r s u sG G
0.232
0.001(0.213–0.333)
BMD spine AA versus AG
A A+A Gv e r s u sG G
0.77
0.001 (0.16–0.291)
History of fractures AA versus AG
A A+A Gv e r s u sG G
0.009 (12.94–13.059)
0.001 (59.85–60.146)
many studies on genetic analysis. Since this is a pilot and
comparative study, one can draw reasonable conclusions
aboutthegeneticinﬂuenceonosteoporosisamongtheethnic
Saudi Arabian population. As many researchers resort to
GWAS to get minimal new data, we opted to study the
inﬂuence of reported target osteoporotic genes upon the
white race.
Inconclusion,thereisstrongsimilarityoftheSNPsinthe
genes that inﬂuence BMD, osteoporosis, and fragility frac-
tures among the reported SNPs and genes in the Caucasian
race and the ethnic Saudi population. These may not be the
only SNPs which inﬂuence osteoporosis risk, but it gives a
direction to study the reported targeted genes among the
Saudi population.
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